Here are the stocks that are in news today: Unichem Labs: Company gets USFDA nod for asthma drug Muthoot Finance: Company eyes disbursal of Rs 300 crore personal loans Som Distilleries’ subsidiary acquired Brewery in Odisha for Rs 46 crore ICICI Bank: Bank aims to grow home loan book to Rs 2 trillion by FY20…Continue Reading
Stock Market updates
Stock market updates, news, intraday trading tips, opening bells updates, closing bells updates, stocks in focus today news, top gainers, top losers.
Investelite Research team publishes daily blogs, news, share market updates, stock market updates, share market tips, stock market tips.
Investelite Research is a SEBI registered and leading provider of stock market tips.
We present a wide range of intraday cash tips, equity cash tips, future tips, nifty tips, options tips, commodity tips and Forex tips for the global trading market.
We get in touch with our clients to offer live tips through High-Speed SMS Gateway that ensures instant delivery of a message in real time.
Investelite Research is SEBI registered and ISO certified. The team of Investelite Research embraces veteran technical analysts, who forecast market smartly, keeping risk-factors in mind with a vision of owning the profits.
Here are stocks that are in news today: Dr. Reddy Lab: Company announces launch of Repatha in India Aurobindo Pharma: The firm has received USFDA approval for Ibuprofen OTC capsules. It is a painkiller drug Tata Power: Tata Power Renewable Energy commissioned 100 MW solar capacity in Andhra Pradesh Strides Shasun receives USFDA approval for…Continue Reading
Here are stocks that are in news today: June Auto Sales number: Tata Motors total domestic sales jump 54% to 56,773 units Vs 36,836 units, YoY M&M total auto sales up 26% at 45,155 units Vs 35,759 units, YoY Eicher Motors total VECV sales up 63% at 6,390 units Vs 3,921 units, YoY Maruti Suzuki…Continue Reading
Here are stocks that are in news today: Ex-Bonus- New India Assurance Company 1:1 Ex- Split: Filatex India From Rs 10 to Rs 2 Gallantt Ispat board meeting on June 28 to consider stock split IndusInd Bank to acquire IL&FS’ brokerage business PNB Housing Finance plans to raise Rs 10,000 cr via bonds Shriram Transport…Continue Reading
Here are stocks that are in news today: Piramal Enterprises to sell arm Piramal Imaging to Alliance Medical Acquisitionco Fortis Healthcare board meeting to consider Q4 results adjourned on June 25; to be re-convened on June 26, 2018 JMC secures new orders of Rs 1,966 crore Aurobindo Pharma receives USFDA approval for Ertapenem injection Bank…Continue Reading
The demand will be raised from Vodafone India before its merger with Idea Cellular Shares of Idea CellularNSE -5.95 % fall over 3 per cent in early trade on Monday after reports that the mega-merger deal of the company with Vodafone India may not meet the expected June 30 timeline as the telecom department is…Continue Reading
Here are stocks that are in news today: Phoenix Mills’ subsidiary acquires under-construction retail development in Indore for Rs 2.34 billion Tata Power: Gets defence industrial licence nod from SEZ BoA Dena Bank approved raising of the fund upto an amount of Rs 1800 crore Bombay Dyeing signed term sheet to acquire additional 52.11% stake…Continue Reading
Here is a list of stocks that are likely to be in focus in today’s trading session: Stocks in the news: ICICI Bank, Can Fin Homes, HCL Tech, Tata Motors, Indiabulls Real Estate ICICI Bank| Can Fin Homes| HCL Tech| Tata Motors| Indiabulls Real Estate are the stocks which are in news today. Here are the stocks…Continue Reading
Here is a list of stocks that are likely to be in focus in today’s trading session: Cipla receives final approval for Generic Depo-Testosterone Adani Transmission: Company acquires 100 percent equity in Ghatampur SPV Indiabulls Real Estate proposes to issue NCD worth Rs 480 crore Bosch: Company plans to invest Rs 1,700 crore in India in next 3…Continue Reading
Here is a list of stocks that are likely to be in focus in today’s trading session: Cipla has received final approval for its abbreviated new drug application for Efavirenz tablets 600mg from the USFDA. It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults. Infosys expands footprint…Continue Reading